Goldman Sachs Group Inc Emergent Bio Solutions Inc. Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 620,977 shares of EBS stock, worth $6.28 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
620,977
Previous 579,392
7.18%
Holding current value
$6.28 Million
Previous $3.7 Million
48.19%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding EBS
# of Institutions
191Shares Held
41.3MCall Options Held
899KPut Options Held
256K-
Black Rock Inc. New York, NY3.84MShares$38.8 Million0.0% of portfolio
-
Oak Hill Advisors LP New York, NY3.61MShares$36.5 Million3.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.54MShares$35.8 Million0.0% of portfolio
-
State Street Corp Boston, MA2.45MShares$24.7 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.38MShares$24.1 Million0.01% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $504M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...